Ross Muken Transforms Leadership at SOPHiA GENETICS
- SOPHiA GENETICS announced leadership changes on November 5, 2024.
- George Cardoza has been appointed as the new Chief Financial Officer.
- The leadership changes aim to enhance operational effectiveness and drive innovation.
On November 5, 2024, SOPHiA GENETICS, a leader in data-driven medicine, announced the promotion of Ross Muken to the position of President. Muken, who has been with the company since February 2021 and served as Chief Financial Officer and Chief Operating Officer, will now oversee global business operations and work closely on strategic planning with CEO Jurgi Camblong. George Cardoza has been appointed as the new Chief Financial Officer, bringing over 30 years of experience in precision medicine and clinical diagnostics. Cardoza's previous roles include significant leadership positions at NeoGenomics Laboratories and Quest Diagnostics. His expertise is expected to enhance SOPHiA GENETICS’s operational effectiveness and innovation efforts. This leadership change reflects the company’s commitment to growth and improving its business strategies in an evolving healthcare landscape.